Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase

Connect

Matthew G Law and Robert G Batey

Med J Aust 2003; 179 (2): . || doi: 10.5694/j.1326-5377.2003.tb05459.x
Published online: 21 July 2003

Matthew G Law,* Robert G Batey†

Correspondence: mlaw@nchecr.unsw.edu.au

1. Commonwealth Department of Health and Ageing. Return on investment in needle and syringe programs in Australia. Canberra: Department of Health and Ageing, 2002. Available at: http://www.health.gov.au/pubhlth/publicat/hac.htm (accessed Jun 2003).

Online responses are no longer available. Please refer to our instructions for authors page for more information.